NCT07733050 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

JPRN-jRCT2071260068 clinical trial report covering SFG-02, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734012 clinical trial report covering Mycophenolate Mofetil, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07732491 clinical trial report covering Culmerciclib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733466 clinical trial report covering Cetuximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734870 clinical trial report covering Tirzepatide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733934 clinical trial report covering Teverelix Trifluoroacetate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733180 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734038 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07737925 clinical trial report covering Xaluritamig, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262884 clinical trial report covering HX9428, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262897 clinical trial report covering Albipagrastim alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.